Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide Phase 2 Trial in Type 2 Diabetes
NCT03311724Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2017
- Primary completion
- Apr 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Oct 2017; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03311724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03311724.